Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NPCE
Stock Latest News
Company Announcements
Neuropace’s Innovative Approach to Treating Lennox-Gastaut Syndrome
9d ago
NPCE
Premium
Ratings
NeuroPace’s Strategic Advancements and Revenue Growth Underpin Buy Rating Despite Challenges
9d ago
NPCE
Premium
Company Announcements
NeuroPace Reports Record Revenue and Raises Guidance
10d ago
NPCE
Premium
The Fly
NeuroPace reports Q2 EPS (26c), consensus (22c)
11d ago
NPCE
Premium
The Fly
NeuroPace: On track to submit Nautilus data to FDA in 2H
11d ago
NPCE
Premium
The Fly
NeuroPace raises FY25 revenue view to $94M-$98M, consensus $94.78M
11d ago
NPCE
Premium
Pre-Earnings
NPCE Upcoming Earnings Report: What to Expect?
13d ago
NPCE
Premium
The Fly
NeuroPace ‘commends’ CMS for maintaining FY25 epilepsy reimbursement structure
22d ago
NPCE
Premium
The Fly
Citizens JMP pharmaceuticals analysts hold analyst/industry conference call
2M ago
NPCE
RAPP
Premium
Company Announcements
NeuroPace Appoints New CFO Amid Strategic Shift
2M ago
8K
NPCE
Premium
The Fly
NeuroPace CFO Rebecca Kuhn to depart, Patrick Williams to succeed
2M ago
NPCE
STAA
Premium
The Fly
Femasys appoints Nicholas as CCO
2M ago
FEMY
NPCE
Premium
Company Announcements
NeuroPace Holds Virtual Annual Stockholders Meeting
2M ago
8K
NPCE
Premium
Company Announcements
NeuroPace Secures $75 Million Credit Facility with MidCap
3M ago
8K
NPCE
Premium
Ratings
Buy Rating for NeuroPace: Strong Revenue Growth and Efficacy of RNS System Drive Investment Appeal
3M ago
NPCE
Premium
The Fly
NeuroPace initiated with a Buy at H.C. Wainwright
3M ago
NPCE
Premium
Ratings
NeuroPace: Buy Rating Affirmed Amid Promising NAUTILUS Study Outcomes and Favorable FDA Engagement
3M ago
NPCE
Premium
Ratings
Optimistic Outlook for NeuroPace: Buy Rating Justified by Subgroup Success and Growth Potential
3M ago
NPCE
Premium
Ratings
NeuroPace’s Promising Prospects: Buy Rating Affirmed Despite Initial Study Setback
3M ago
NPCE
Premium
The Fly
Leerink says NeuroPace results disappointing, sees hope on totality of data
3M ago
NPCE
Premium
Company Announcements
NeuroPace Announces Promising NAUTILUS Study Results
3M ago
8K
NPCE
Premium
The Fly
NeuroPace NAUTILUS trial met primary 12-week post-implant safety endpoint
3M ago
NPCE
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
